Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Phase 3
348
about 2.3 years
18–65
1 site in CA
What this study is about
This trial is testing repurposed drug treatments for Long Covid in adults. Participants will take either pirfenidone, upadacitinib, or a placebo for 842 days to see if the drugs improve symptoms like fatigue and breathing. It aims to assess the safety and effectiveness of these treatments.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Pirfenidone
- 2.Take Placebo for pirfenidone
- 3.Take Placebo for upadacitinib
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
pirfenidone, upadacitinib
oral (Oral Tablet), oral (Oral Solution)
Primary: Symptom Burden Questionnaire (SBQ) Subscales
Secondary: Exercise capacity assessed by the 6-minute walk test (6MWT), General participant reported overall well-being using the Patient Reported Outcome Measurement Information System (PROMIS)-29 questionnaire, Safety and tolerability of the study drugs in participants with Long Covid, Worsening Long Covid Symptoms Measured by SBQ Subscales